CCCC Financials
C4 Therapeutics Inc - Financial statements & key metrics
Stock Price
$3.87
Market Cap
$425.68M
P/E Ratio
-2.5
EPS
$-1.67
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$35.58M
Gross Profit
-
Operating Income
-
Net Income
$-105.32M
EPS (Diluted)
$-1.52
Balance Sheet Highlights
Total Assets
$349.60M
Total Liabilities
$133.62M
Shareholders Equity
-
Cash & Equivalents
$55.50M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-65.16M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-210.9%
ROE
-60.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CCCC revenue?
CCCC's most recent quarterly revenue was $35.58M. Annual revenue can be calculated by summing the four most recent quarters.
Is CCCC profitable?
CCCC reported a loss of $105.32M in the most recent quarter.
What is CCCC market cap?
CCCC has a market capitalization of $425.68M, making it a small-cap stock.
Does CCCC have debt?
View CCCC's balance sheet for debt information.
What is CCCC cash flow?
Cash flow data is available in the full financial statements.